Suppr超能文献

相似文献

1
Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling.
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5891-E5899. doi: 10.1073/pnas.1701990114. Epub 2017 Jun 28.
2
Phospho-mimetic CD3ε variants prevent TCR and CAR signaling.
Front Immunol. 2024 May 8;15:1392933. doi: 10.3389/fimmu.2024.1392933. eCollection 2024.
3
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy.
Cell. 2020 Aug 20;182(4):855-871.e23. doi: 10.1016/j.cell.2020.07.018. Epub 2020 Jul 29.
4
Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function.
Nat Immunol. 2020 Aug;21(8):902-913. doi: 10.1038/s41590-020-0732-3. Epub 2020 Jul 20.
5
Cooperative Interaction of Nck and Lck Orchestrates Optimal TCR Signaling.
Cells. 2021 Apr 7;10(4):834. doi: 10.3390/cells10040834.
7
Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells.
PLoS One. 2014 Jan 15;9(1):e85934. doi: 10.1371/journal.pone.0085934. eCollection 2014.
8
Local changes in lipid environment of TCR microclusters regulate membrane binding by the CD3ε cytoplasmic domain.
J Exp Med. 2012 Dec 17;209(13):2423-39. doi: 10.1084/jem.20120790. Epub 2012 Nov 19.
9
T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury.
FASEB J. 2009 Jun;23(6):1663-71. doi: 10.1096/fj.08-117283. Epub 2009 Jan 23.

引用本文的文献

1
Sabotaging TCR signaling-LAG3 interferes with the CD3ε-LCK interaction.
Cell Res. 2025 Aug 22. doi: 10.1038/s41422-025-01168-7.
2
Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation.
J Transl Med. 2025 Jul 25;23(1):834. doi: 10.1186/s12967-025-06857-w.
3
Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond.
Cell Mol Immunol. 2025 Jun 6. doi: 10.1038/s41423-025-01304-8.
4
HIV Nef disrupts Lck signaling by inducing aberrant phosphorylation of its substrates.
Immunohorizons. 2025 Apr 26;9(6). doi: 10.1093/immhor/vlaf016.
6
Charged substrate treatment enhances T cell mediated cancer immunotherapy.
Nat Commun. 2025 Feb 12;16(1):1585. doi: 10.1038/s41467-025-56858-y.
7
Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells.
Signal Transduct Target Ther. 2025 Jan 15;10(1):20. doi: 10.1038/s41392-024-02096-5.
9
Charge-based immunoreceptor signalling in health and disease.
Nat Rev Immunol. 2025 Apr;25(4):298-311. doi: 10.1038/s41577-024-01105-6. Epub 2024 Nov 11.
10
From TCR fundamental research to innovative chimeric antigen receptor design.
Nat Rev Immunol. 2025 Mar;25(3):212-224. doi: 10.1038/s41577-024-01093-7. Epub 2024 Oct 21.

本文引用的文献

1
Recruitment of calcineurin to the TCR positively regulates T cell activation.
Nat Immunol. 2017 Feb;18(2):196-204. doi: 10.1038/ni.3640. Epub 2016 Dec 12.
2
Regulation of T cell signalling by membrane lipids.
Nat Rev Immunol. 2016 Nov;16(11):690-701. doi: 10.1038/nri.2016.103. Epub 2016 Oct 10.
4
Engineered T cells: the promise and challenges of cancer immunotherapy.
Nat Rev Cancer. 2016 Aug 23;16(9):566-81. doi: 10.1038/nrc.2016.97.
8
T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
J Clin Invest. 2015 Jun;125(6):2220-7. doi: 10.1172/JCI78087. Epub 2015 May 11.
9
Lipid in T-cell receptor transmembrane signaling.
Prog Biophys Mol Biol. 2015 Sep;118(3):130-8. doi: 10.1016/j.pbiomolbio.2015.04.004. Epub 2015 May 1.
10
Neoantigens in cancer immunotherapy.
Science. 2015 Apr 3;348(6230):69-74. doi: 10.1126/science.aaa4971.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验